Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
International Journal of Impotence Research
|
May 5, 2022
Are finasteride-related penile curvature/Peyronie's disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
Nicolò Schifano, Paolo Capogrosso, Luca Boeri, et al.
European Urology Oncology
|
May 18, 2019
Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer
Armando Stabile, Paolo Dell'Oglio, Francesco De Cobelli, et al.
Journal of the National Cancer Institute
|
June 10, 2020
Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer
Marco Bandini, Jeffrey S Ross, Daniele Raggi, et al.
World Journal of Urology
|
June 8, 2025
Minimally invasive surgical techniques (MISTs) for benign prostatic hyperplasia: results from a Delphi consensus project to shed light on controversial topics
Federica Passarelli, Daniele Castellani, Silvia Secco, et al.
Cancers
|
November 13, 2021
The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort Analysis
Matteo Ferro, Francesco Del Giudice, Giuseppe Carrieri, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
International Journal of Impotence Research
|
May 5, 2022
Are finasteride-related penile curvature/Peyronie's disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
Nicolò Schifano, Paolo Capogrosso, Luca Boeri, et al.
European Urology Oncology
|
May 18, 2019
Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer
Armando Stabile, Paolo Dell'Oglio, Francesco De Cobelli, et al.
Journal of the National Cancer Institute
|
June 10, 2020
Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer
Marco Bandini, Jeffrey S Ross, Daniele Raggi, et al.
World Journal of Urology
|
June 8, 2025
Minimally invasive surgical techniques (MISTs) for benign prostatic hyperplasia: results from a Delphi consensus project to shed light on controversial topics
Federica Passarelli, Daniele Castellani, Silvia Secco, et al.
Cancers
|
November 13, 2021
The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort Analysis
Matteo Ferro, Francesco Del Giudice, Giuseppe Carrieri, et al.
Page
of 3